Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220004510 220010906 1.65 74 null 2017-01-25 2017-01-26 Cytarabine Low Dose Y N 220026194 CYTARABINE
220004511 220010906 1.57 110.9 Disease modification (D) 2014-10-28 2014-10-28 CYTARABINE N N 220026194 CYTARABINE
220004512 220001801 null 65 Palliative (P) 2017-09-24 2017-09-24 Cytarabine Low Dose N N 220026196 CYTARABINE
220004513 220001801 1.6 null Curative (C) 2013-04-02 2013-04-02 LI-1 TRIAL 01 null 220026196 TRIAL
220004514 220001801 0 null Palliative (P) null 2016-09-18 Cytarabine Low Dose N N 220026196 CYTARABINE
220004515 220001801 0 null null 2013-12-06 2013-12-24 AML17 TRIAL 1 N 220026196 AML17 TRIAL
220004516 220001801 null 68.8 Curative (C) 2017-07-11 2017-07-11 AML17 TRIAL N N 220026196 AML17 TRIAL
220004517 220021195 1.85 75.6 Disease modification (D) null 2016-07-29 Trial Unspecified null null 220026212 TRIAL
220004518 220021195 1.6 71 Curative (C) 2015-03-14 2015-03-14 AML17 TRIAL N N 220026212 AML17 TRIAL
220004519 220021195 1.73 null Curative (C) 2013-09-17 2013-09-17 AML17 TRIAL 1 null 220026212 AML17 TRIAL
220004520 220021195 1.59 null Palliative (P) 2016-05-22 2016-05-24 CYTARABINE N null 220026212 CYTARABINE
220004521 220021195 1.58 58.6 Palliative (P) 2015-03-01 2015-03-01 Trial Unspecified Y N 220026212 TRIAL
220004522 220001802 1.79 48.8 Palliative (P) 2013-02-19 2013-02-21 Cytarabine Low Dose 02 N 220026227 CYTARABINE
220004523 220001802 null null Palliative (P) 2013-02-17 2013-04-05 CYTARABINE N N 220026227 CYTARABINE
220004524 220001802 1.59 72.9 Palliative (P) 2013-02-27 2013-03-01 Cytarabine Low Dose 02 N 220026227 CYTARABINE
220004525 220001802 1.74 68 Disease modification (D) 2015-12-19 2015-12-28 Cytarabine low (10to20mg/m2) IV/SC N N 220026227 CYTARABINE
220004526 220001802 1.6 89.6 Curative (C) 2014-02-10 2014-02-10 Trial Unspecified 01 Y 220026227 TRIAL
220004527 220001802 0 null Palliative (P) 2016-12-31 2017-01-01 Trial Unspecified 01 N 220026227 TRIAL
220004528 220001802 1.55 73.7 Curative (C) 2017-11-04 2017-11-08 Trial Unspecified Y N 220026227 TRIAL
220004529 220001802 1.48 77.4 Palliative (P) 2018-01-13 2018-01-28 Trial Unspecified Y N 220026227 TRIAL
220004530 220022148 1.63 82.3 null 2013-07-19 2013-07-19 AML17 TRIAL N Y 220026248 AML17 TRIAL
220004531 220001803 null 84.6 Curative (C) 2015-03-18 2015-03-22 AML17 TRIAL Y N 220026249 AML17 TRIAL
220004532 220001803 1.65 95.5 Curative (C) 2013-04-05 2013-04-06 Trial Unspecified 01 N 220026249 TRIAL
220004533 220001803 1.58 92.499 Curative (C) 2014-01-18 2014-01-20 AML17 TRIAL Y null 220026249 AML17 TRIAL
220004534 220001803 1.57 79.4 Not known (9) 2017-11-25 2017-11-30 AML17 TRIAL N null 220026249 AML17 TRIAL
220004535 220001804 0 null Not known (9) 2014-05-22 2014-05-22 AML17 TRIAL null N 220026257 AML17 TRIAL
220004536 220001805 null 105.3 Curative (C) 2017-02-12 2017-02-12 Trial Unspecified Y N 220026258 TRIAL
220004537 220001805 1.57 93 Curative (C) 2016-09-05 2016-09-05 AML17 TRIAL 01 N 220026258 AML17 TRIAL
220004538 220001805 1.85 null Curative (C) 2018-03-06 2018-03-06 Cytarabine Low Dose 2 N 220026258 CYTARABINE
220004539 220001806 1.75 null Palliative (P) 2014-09-17 2014-09-21 Cytarabine Low Dose N N 220026263 CYTARABINE
220004540 220001806 1.63 65 Curative (C) 2017-06-14 2017-06-14 AML17 TRIAL 01 N 220026263 AML17 TRIAL
220004541 220001807 1.86 85 Disease modification (D) 2013-02-14 2013-02-24 Cytarabine Low Dose 2 null 220026266 CYTARABINE
220004542 220001808 1.65 null Curative (C) 2013-03-06 2013-03-06 AML17 TRIAL 01 N 220026267 AML17 TRIAL
220004543 220001808 1.64 null Palliative (P) 2017-10-26 2017-10-26 CYTARABINE N N 220026267 CYTARABINE
220004544 220001808 1.77 83.5 Curative (C) 2016-09-27 2016-09-28 Trial Unspecified 01 null 220026267 TRIAL
220004545 220018671 1.62 null Palliative (P) 2013-06-08 2013-06-08 AML17 TRIAL null N 220026273 AML17 TRIAL
220004546 220001809 null 90 Disease modification (D) 2013-04-16 2013-04-16 Cytarabine low (10to20mg/m2) IV/SC N N 220026275 CYTARABINE
220004547 220001809 null null Adjuvant (A) 2015-12-18 2015-12-20 Cytarabine Low Dose N N 220026275 CYTARABINE
220004548 220001810 1.63 68 null 2016-04-16 2016-04-16 AML17 TRIAL N N 220026282 AML17 TRIAL
220004549 220001810 1.59 null Disease modification (D) 2018-01-09 2018-01-17 Cytarabine Low Dose N N 220026282 CYTARABINE
220004550 220001810 1.65 100.9 null 2017-12-18 2017-12-19 Trial Unspecified 1 N 220026282 TRIAL
220004551 220001811 1.68 99 Curative (C) 2015-09-23 2015-09-23 AML17 TRIAL 02 N 220026288 AML17 TRIAL
220004552 220001812 1.8 110 Not known (9) 2013-01-18 2013-01-18 Trial Unspecified Y N 220026289 TRIAL
220004556 220001813 null null Disease modification (D) 2015-09-19 2015-09-22 CYTARABINE N N 220026294 CYTARABINE
220004557 220001813 null 83.6 Curative (C) 2013-04-02 2013-04-02 AML17 TRIAL 1 N 220026294 AML17 TRIAL
220004558 220001813 1.73 null Curative (C) 2013-09-07 2013-09-19 Trial Unspecified Y N 220026294 TRIAL
220004559 220001813 1.7 null Palliative (P) 2017-04-04 2017-04-04 CYTARABINE N N 220026294 CYTARABINE
220004560 220001813 1.6 82 Curative (C) 2017-06-26 2017-06-29 Trial Unspecified Y N 220026294 TRIAL
220004561 220001814 null 58 Palliative (P) 2015-04-08 2015-04-12 CYTARABINE 02 N 220026308 CYTARABINE
220004562 220010917 null 81.9 Curative (C) 2015-04-20 2015-04-20 AML17 TRIAL Y null 220026309 AML17 TRIAL